Small changes in hospital practice bring significant benefits to rectal cancer patientsSeptember 22, 2003Copenhagen, Denmark: Small but important changes in hospital practice during the treatment of rectal cancer can produce significant benefits to patients, according to research from Sweden. Professor Lars P'åhlman, a professor and consultant surgeon at the Department of Surgery at University Hospital Uppsala, Sweden, told delegates at ECCO12 - the European Cancer Conference, that five-year survival in patients with a cancer that has always been notoriously hard to treat successfully, had jumped from 50% to 60% in the last 10 years in Sweden He said that during the 1970s rectal cancer patients fared 5-10% less well than those with colon cancer. Trials using radiotherapy established that the local recurrence rate could be halved from 30% to 15%, but also highlighted the fact that about 50% of patients were being operated upon by surgeons doing less than one rectal cancer operation a year. He said: "Some centres in Sweden started to concentrate surgery in a few hands and those centres have shown much better results than other centres where there was no concentration. During the late 80s and early 90s, several hospitals were closed due to political reasons. Most of those hospitals were low volume hospitals. Several training courses were established where surgeons were trained in a new technique which gradually, combined with radiotherapy, became a common procedure. "We started the Swedish rectal cancer registry for quality assurance and control. All rectal cancer patients are registered and now we have five years follow-up indicating that rectal cancer surgery has changed dramatically in Sweden during the last ten years. Rectal cancer patients are now reaching almost 60% five-year survival and have been doing better than colon cancer patients during the last five years. "Therefore, changes during the last 20 years in Sweden have diminished the local recurrence rate from more than 30% to less than 10%. This reduction is a result of good surgery and selective use of radiotherapy, and has had an enormous impact on cancer survival. To our knowledge, Sweden is the only country where rectal cancer patients are doing better than those with colon cancer. "A new project in Sweden will be exploring whether this dramatic improvement in survival is due to the fact that previously rectal cancer patients had been treated less well than colon cancer patients and have now reached the same level, or whether there should be a difference between colon and rectal cancer patients and that maybe we should be concentrating on improving the treatment for colon cancer now." There is no abstract from Professor Lars P'åhlman who will be speaking at a special focus session "How to improve cancer care in Europe" on Thursday 25 September at 12.15 hrs CET in Room C1-M5. | |||||||||||||||||||||
|
Related Colon Cancer Current Events and Colon Cancer News Articles Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Combining targeted therapy drugs may treat previously resistant tumors A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. A Simple Blood Test for Colon Cancer People are often reluctant to undergo a routine but painful colonoscopy ― but the consequences can be fatal. According to the American Cancer Society, colon cancer is the third most common cancer found in American men and women and kills about 50,000 Americans every year. Adalimumab may reduce health-care costs for Crohn's disease patients Inflammatory bowel disease (IBD) is a term that refers to both ulcerative colitis (UC) and Crohn's disease (CD). IBD occurs most frequently in people in their late teens and twenties. There have been cases in children as young as two years old and in older adults in their seventies and eighties; men and women have an equal chance of getting the disease. Washington University scientists first to sequence genome of cancer patient For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots. Minority patients discouraged from cancer screening by negative messages New behavioral science research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, found that constantly emphasizing the negative consequences of a lack of cancer screening among minorities can actually make them less likely to go for screening. Sibling study could lead to better treatments for inherited form of colon cancer Researchers at Huntsman Cancer Institute (HCI) believe they may be one step closer to understanding how certain forms of colon cancer develop. What's the role of beta-catenin in colorectal cancers? Beta-catenin, a central molecule of the Wnt-signaling pathway was previously known to involve in the tumorigenesis of various gastrointestinal cancers such as gastric cancer and colon cancer. Jefferson Department of Surgery announces new pancreas tumor registry Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR). Supercomputer provides massive computational boost to biomedical research at TGen In less time than the blink of an eye, the Translational Genomics Research Institute's new supercomputer at Arizona State University can do operations equal to every dollar in the recent Wall Street bailout. More Colon Cancer Current Events and Colon Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||